Bisphenol A exposure is associated with decreased lung function

Adam J Spanier1, Elizabeth K Fiorino2, Leonardo Trasande3

  • 1Department of Pediatrics, Penn State University, Hershey, PA; Department of Public Health Sciences, Penn State University, Hershey, PA.

Insights

Bisphenol A (BPA) exposure in children was linked to reduced small airway function and indicators of pulmonary obstruction. Further research is needed to confirm these findings and explore potential reverse causality.

Area of Science:

  • Environmental Health
  • Pediatric Pulmonology
  • Toxicology

Background:

  • Bisphenol A (BPA) is an endocrine-disrupting chemical with widespread human exposure.
  • Potential adverse effects of BPA on respiratory health in children are not fully understood.
  • Lung function and exhaled nitric oxide (FeNO) are key indicators of respiratory health.

Purpose of the Study:

  • To investigate the association between urinary BPA concentrations and lung function measures in US children.
  • To examine the relationship between BPA exposure and exhaled nitric oxide (FeNO) in pediatric populations.
  • To assess potential impacts of BPA on small airway function and overall pulmonary obstruction.

Main Methods:

  • Cross-sectional analysis of 661 US children aged 6-19 years from the 2007-2010 NHANES.
  • Urinary BPA concentration was measured as a biomarker of exposure.
  • Lung function (FEV1, FVC, FEF2575, FEV1/FVC) and FeNO were assessed and analyzed in relation to BPA levels.

Main Results:

  • Higher urinary BPA concentrations were significantly associated with decreased percent predicted forced expiratory flow 25%-75% (%FEF2575) and percent predicted FEV1/FVC.
  • Children in the highest quartile of BPA exposure showed a 10% decrease in %FEF2575 and a 3% decrease in %FEV1/FVC compared to the lowest quartile.
  • No significant associations were found between BPA exposure and percent predicted FEV1, percent predicted FVC, or FeNO.

Conclusions:

  • BPA exposure in children is associated with modest reductions in small airway function (%FEF2575) and indicators of pulmonary obstruction (%FEV1/FVC).
  • The findings suggest a potential impact of BPA on specific aspects of lung health in children.
  • The possibility of reverse causality cannot be excluded, warranting further longitudinal investigation.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K